[ad_1]
API major, Lasa Supergenerics Ltd. Received WHO Certificate of Good Manufacturing Practices from the Food and Drug Administration authorities for its manufacturing facility situated at Khed (Ratnagiri).
Commenting on the development, Dr. Omkar Herlekar, Chairman – Lasa Supergenerics Limited, “WHO Good Manufacturing Practice certificate can be obtained by constant efforts towards improving the quality assurance as well as implementation of various systems on place, though we already have GMP for our other major units, we are also proud to receive this recognition for our Unit Located in Khed with the efforts of our Hardworking Team.“
WHO GMP covers all aspects of production starting from the materials, premises and equipment to the training and personal hygiene of staff. Detailed, written procedures which are essential for each process that could affect the quality of the finished product. Systems to provide documented proof that correct procedures are consistently followed at each step in the manufacturing process – every time a product is made.
Besides saving costs with the help of consistent procedure in safe environment WHO GMP also helps in increasing the customers confidence for the company’s products, enhances safety management controls, reduce operating costs by eliminating penalties which may be imposed due to non-compliance, attract exports attention etc.
WHO GMP guidelines are not prescriptive instructions on how to manufacture products. They are a series of general principles that must be observed during manufacturing.
About Lasa (BSE: 540702; NSE: LASA)
Incorporated in 2011, Lasa is a globally well trusted brand with high quality products, accepted by large companies across the globe. Our Company is the pioneer and amongst the leading players in the manufacturing of Veterinary APIs, with a well-established brand known for its high-quality products amongst various customers. The Company has its unit with state-of-art manufacturing facilities located at Mahad & Chiplun, Maharashtra with a total installed capacity of 4,300 MT. The Company has over 25% of APIs exported to countries like Australia, Bangladesh, Middle East, China, Turkey, Egypt, Jordan, Korea etc.
[ad_2]
Source link
- COVID case rates hit new high for England, study finds - April 7, 2022
- Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
- SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
- Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- ‘Friendly viruses’ can be the next big thing in the history of medical research and more - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022
